z-logo
open-access-imgOpen Access
Targeting PIM2 by JP11646 results in significant antitumor effects in solid tumors
Author(s) -
Eriko Katsuta,
Malgorzata GilMoore,
Justine Moore,
Mohamed Yousif,
Alex A. Adjei,
Yi Ding,
Justin Caserta,
Carmen M. Baldino,
Kelvin H. Lee,
Irwin H. Gelman,
Kazuaki Takabe,
Mateusz Opyrchal
Publication year - 2022
Publication title -
international journal of oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.405
H-Index - 122
ISSN - 1019-6439
DOI - 10.3892/ijo.2022.5404
Subject(s) - proteasome inhibitor , apoptosis , bortezomib , cancer research , biology , cell cycle , gene knockdown , oncogene , in vivo , cancer , proteasome , protein degradation , cancer cell , ectopic expression , cell growth , immunology , cell culture , microbiology and biotechnology , multiple myeloma , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom